Comparative hepatitis A seroepidemiology in 10 European countries.

Authors:
Address: Health Protection Agency, Health Protection Services, Colindale, London, UK.
Journal:


Publication:

abstract

SUMMARYThe WHO recommends hepatitis A virus (HAV) immunization according to level of transmission and disease burden. We aimed to identify susceptible age groups by standardized serosurveys to inform HAV vaccination policy in participating countries: Belgium, Czech Republic, England, Finland, Germany, Italy, Lithuania, Malta, Romania, and Slovakia. Each country tested national serum banks (n=1854-6748), collected during 1996-2004, for anti-HAV antibodies. Local laboratory results were standardized to common units. Forty-one per cent of those aged <30 years and 6% of those aged ⩾30 years were susceptible to HAV in Romania; compared to 70-94% and 26-71%, respectively, elsewhere. Romania reported high HAV incidence in children and young adults. Other countries reported HAV disease primarily in older risk groups. The results suggest low level of HAV transmission in most of Europe. Romania, however, appeared as an area with intermediate transmission. Vaccination of risk groups in countries with high susceptibility of young and middle-aged adults needs to be continued.



Related Articles
Towards elimination: measles susceptibility in Australia and 17 European countries.
Bull World Health Organ. 2008
Towards elimination: measles susceptibility in Australia and 17 European countries.
Andrews N, Tischer A, Siedler A, Pebody RG, Barbara C, Cotter S, Duks A, Gacheva N, Bohumir K, Johansen K, et al. Bull World Health Organ. 2008 Mar; 86(3):197-204.
Viral hepatitis in Bucharest.
Bull World Health Organ. 1993
Viral hepatitis in Bucharest.
Paquet C, Babes VT, Drucker J, Sénémaud B, Dobrescu A. Bull World Health Organ. 1993; 71(6):781-6.
Comparative seroepidemiology of diphtheria in six European countries and Israel.
Epidemiol Infect. 2012
Comparative seroepidemiology of diphtheria in six European countries and Israel.
DI Giovine P, Kafatos G, Nardone A, Andrews N, Olander RM, Alfarone G, Broughton K, Cohen D, Kriz B, Mikova I, et al. Epidemiol Infect. 2012 Feb 24; :1-11. Epub 2012 Feb 24.
Review [Viral hepatitis A: when a changing epidemiology implies a different prophylaxis].
Sante. 1998
Review [Viral hepatitis A: when a changing epidemiology implies a different prophylaxis].
Martet G, Morillon M, Debonne JM, Louis FJ. Sante. 1998 Mar-Apr; 8(2):113-7.
Review [Vaccination against hepatitis A].
Recenti Prog Med. 1992
Review [Vaccination against hepatitis A].
Giusti G, Russo M. Recenti Prog Med. 1992 Jun; 83(6):313-20.

To top Home


Show map | Diseases | Vaccination | Chronic disease | Medicine | Pregnancy | Heat & Sunburn | Cold | Security | Useful tips | Faq | News

TraveldoctorOnline 2001 • Disclaimer webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.